Tshz1 Regulates Pancreatic β-Cell Maturation

Area of Science:

• Developmental biology
• Endocrinology
• Molecular genetics

Background:

• The homeodomain transcription factor Pdx1 is essential for pancreas development and beta-cell function.
• Human stem cell differentiation into functional beta-cells remains inefficient.
• Understanding Pdx1-regulated genes is key to improving beta-cell differentiation.

Purpose of the Study:

• To identify direct Pdx1 target genes involved in pancreas differentiation.
• To investigate the role of Teashirt zinc finger 1 (Tshz1) in beta-cell development and function.
• To explore the potential involvement of Tshz1 in type 2 diabetes.

Main Methods:

• Chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) in mouse pancreata.
• Analysis of Tshz1-null mouse models for developmental defects.
• Assessment of glucose tolerance and insulin secretion in adult Tshz1(+/-) mice.
• Quantification of TSHZ1 levels in human islets from type 2 diabetes donors.

Main Results:

• Tshz1 was identified as a direct transcriptional target of Pdx1.
• Tshz1 is expressed in developing and mature insulin- and glucagon-positive cells.
• Tshz1 deficiency leads to downregulation of key beta-cell (Pdx1, Nkx6.1) and alpha-cell (MafB, Arx) regulators.
• Adult Tshz1(+/-) mice exhibit glucose intolerance and impaired glucose-stimulated insulin secretion.
• Reduced Pdx1 and Clec16a expression was observed in Tshz1(+/-) islets.
• TSHZ1 levels are decreased in human islets from individuals with type 2 diabetes.

Conclusions:

• Tshz1 is a critical component of the transcriptional network regulating beta-cell maturation.
• Dysregulation of Tshz1 may contribute to the pathogenesis of type 2 diabetes.
• Tshz1 represents a potential therapeutic target for diabetes treatment.